ArticleOncoimmunology2025

TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8

Ran Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.